Form 4: Tandem Diabetes Care CEO John F. Sheridan Reports Stock Transactions
SEC Form 4 Filing
John F. Sheridan, President and CEO of Tandem Diabetes Care, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- On February 18, 2025, John F. Sheridan, the President and CEO of Tandem Diabetes Care Inc., reported transactions involving common stock and restricted stock units (RSUs).
- These transactions included the vesting of RSUs and the subsequent withholding of shares by the company to cover tax obligations.
- Specifically, 793, 2,237, and 5,472 RSUs vested, resulting in the acquisition of common stock.
- The company withheld 284, 801, and 2,097 shares respectively at a price of $33.47 to satisfy tax withholding requirements.
- Following these transactions, Sheridan directly owns 59,657 shares of Tandem Diabetes Care Inc. common stock and holds 27,358 RSUs.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence and market regulation.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
- The transactions have a minimal impact on employees, customers, suppliers, and creditors.
Key Dates
| Date | Description |
|---|---|
| May 18, 2021 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| May 15, 2022 | First vesting date (25%) for RSUs awarded on May 18, 2021. |
| May 25, 2022 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| May 15, 2023 | First vesting date (33%) for RSUs awarded on May 25, 2022. |
| May 25, 2023 | Date of RSU award pursuant to the 2023 Long-Term Incentive Plan. |
| May 15, 2024 | First vesting date (33%) for RSUs awarded on May 25, 2023. |
| February 18, 2025 | Date of transactions reported in the Form 4 filing, including vesting of RSUs and tax withholding. |
| February 20, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Tandem Diabetes Care, TNDM, John F. Sheridan, Restricted Stock Units, RSU, Stock Options, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.